[Current status and future prospects of stem cell gene therapy for primary immunodeficiency].

Patients affected by primary immunodeficiency (PID) can be cured by allogeneic hematopoietic stem cell transplantation (HSCT). In the absence of HLA-matched donors, however, incidence of HSCT-related complications is observed. Therefore, gene therapy has been developed as a highly desirable alternative treatment for patients lacking suitable donors. Retrovirus-based gene therapy was begun in 1990 for the patients of adenosine deaminase deficiency, followed by X-linked severe combined immunodeficiency, Wiskott-Aldrich syndrome and chronic granulomatous disease. Although treated patients have had excellent immune reconstitution and resolution of ongoing infections, complications such as a lymphoproliferative syndrome and a disappearance of gene-modified cells were observed in some clinical trials. To overcome these, ongoing and upcoming clinical trials use some new strategies. The use of preconditioning chemotherapy makes space in the bone marrow for the gene-treated stem cells and allows engraftment of multi lineage stem/progenitor cells. Self-inactivating vectors in which strong enhancers of long terminal repeat are eliminated may reduce the risk of insertional activation of proto-oncogene resulting in leukemia. These modifications will surely increase the safety and efficacy of stem cell gene therapy for PID.
AuthorsToru Uchiyama, Masafumi Onodera
JournalNihon Rinshò„ Men'eki Gakkai kaishi = Japanese journal of clinical immunology (Nihon Rinsho Meneki Gakkai Kaishi) Vol. 36 Issue 3 Pg. 148-55 ( 2013) ISSN: 1349-7413 [Electronic] Japan
PMID23812072 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Adenosine Deaminase
  • Adenosine Deaminase (deficiency)
  • Agammaglobulinemia (therapy)
  • Genetic Therapy (methods)
  • Granulomatous Disease, Chronic (therapy)
  • Humans
  • Immunologic Deficiency Syndromes (therapy)
  • Severe Combined Immunodeficiency (therapy)
  • Stem Cells
  • Wiskott-Aldrich Syndrome (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: